ANDA 75716, held by PharmoBedient. Paroxetine Hydrochloride.
As of Nov 21, 2026, ANDA 75716 (Paroxetine Hydrochloride), held by PharmoBedient, was first approved by FDA on Mar 8, 2004, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 8, 2004 | Original application | Approved | None posted |
| Paroxetine HydrochlorideEQ 10MG BASE · tablet;oral | Paroxetine Hydrochloride | Discontinued |
| Paroxetine HydrochlorideEQ 20MG BASE · tablet;oral | Paroxetine Hydrochloride | Discontinued |
| Paroxetine HydrochlorideEQ 30MG BASE · tablet;oral | Paroxetine Hydrochloride | Discontinued |
| Paroxetine HydrochlorideEQ 40MG BASE · tablet;oral | Paroxetine Hydrochloride | Discontinued |
| Jul 8, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 6, 2009 | Supplement 11Labeling | Approved | None posted |
| Jul 9, 2007 | Supplement 9Labeling | Approved | None posted |
| Jul 9, 2007 | Supplement 10Labeling | Approved | None posted |
| Feb 27, 2007 | Supplement 5Labeling | Approved | None posted |
| Feb 27, 2007 | Supplement 6Labeling | Approved | None posted |
| Mar 24, 2006 | Supplement 4Labeling | Approved | None posted |
| Oct 25, 2005 | Supplement 3Labeling | Approved | None posted |
| Mar 10, 2005 | Supplement 2Labeling | Approved | None posted |
| Mar 8, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters